These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 15546950)

  • 21. Freeze and Thaw of CD4+CD25+Foxp3+ Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease.
    Florek M; Schneidawind D; Pierini A; Baker J; Armstrong R; Pan Y; Leveson-Gower D; Negrin R; Meyer E
    PLoS One; 2015; 10(12):e0145763. PubMed ID: 26693907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7.
    Szanya V; Ermann J; Taylor C; Holness C; Fathman CG
    J Immunol; 2002 Sep; 169(5):2461-5. PubMed ID: 12193715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory T cells contribute to the immunoregulatory effect on graft versus host reaction after liver transplantation in donor-dominant one-way MHC matching rats.
    Xue F; Chen W; Wang X; Wang L; Xu G; Liang L; Bai X; Liang T
    Transpl Immunol; 2009 Mar; 20(4):232-7. PubMed ID: 19041396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host disease.
    Xia G; Kovochich M; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2004 Nov; 10(11):748-60. PubMed ID: 15505606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation.
    Karim M; Feng G; Wood KJ; Bushell AR
    Blood; 2005 Jun; 105(12):4871-7. PubMed ID: 15713793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of Graft-Versus-Host Disease Control Efficacy by Adoptive Transfer of Type 1 Regulatory T Cells in Bone Marrow Transplant Model.
    Jeon YW; Lim JY; Im KI; Kim N; Nam YS; Song YJ; Cho SG
    Stem Cells Dev; 2019 Jan; 28(2):129-140. PubMed ID: 30381994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
    Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
    Front Immunol; 2018; 9():3104. PubMed ID: 30733722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation.
    Hanash AM; Levy RB
    Blood; 2005 Feb; 105(4):1828-36. PubMed ID: 15494429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells.
    Fernandez I; Zeiser R; Karsunky H; Kambham N; Beilhack A; Soderstrom K; Negrin RS; Engleman E
    J Immunol; 2007 Sep; 179(5):2808-14. PubMed ID: 17709494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-selectin is dispensable for T regulatory cell function postallogeneic bone marrow transplantation.
    Carlson MJ; Fulton LM; Coghill JM; West ML; Burgents JE; Wan Y; Panoskaltsis-Mortari A; Tedder TF; Blazar BR; Serody JS
    Am J Transplant; 2010 Dec; 10(12):2596-603. PubMed ID: 21070606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
    Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
    J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
    Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
    J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts.
    Zhao XY; Wang YT; Mo XD; Zhao XS; Wang YZ; Chang YJ; Huang XJ
    J Transl Med; 2015 May; 13():145. PubMed ID: 25948100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.
    Yang ZG; Wen RT; Feng JS; Cao PJ; Zhou HT; Liu WX
    Anat Rec (Hoboken); 2019 May; 302(5):825-836. PubMed ID: 30312018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A glucocorticoid amplifies IL-2-induced selective expansion of CD4(+)CD25(+)FOXP3(+) regulatory T cells in vivo and suppresses graft-versus-host disease after allogeneic lymphocyte transplantation.
    Xie Y; Wu M; Song R; Ma J; Shi Y; Qin W; Jin Y
    Acta Biochim Biophys Sin (Shanghai); 2009 Sep; 41(9):781-91. PubMed ID: 19727527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
    Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
    Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
    Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro polyclonal activation of conventional T cells with a CD28 superagonist protects mice from acute graft versus host disease.
    Beyersdorf N; Werner S; Wolf N; Hünig T; Kerkau T
    Eur J Immunol; 2015 Jul; 45(7):1997-2007. PubMed ID: 25907100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease.
    Anderson BE; McNiff JM; Matte C; Athanasiadis I; Shlomchik WD; Shlomchik MJ
    Blood; 2004 Sep; 104(5):1565-73. PubMed ID: 15150080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-17 gene ablation does not impact Treg-mediated suppression of graft-versus-host disease after bone marrow transplantation.
    Colonna L; Florek M; Leveson-Gower DB; Sega EI; Baker J; Smith AT; Negrin RS
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1557-65. PubMed ID: 23921175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.